Omega Protein Co. (NYSE:OME) Given Average Rating of “Buy” by Brokerages

Shares of Omega Protein Co. (NYSE:OME) have been given an average recommendation of “Buy” by the seven ratings firms that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $21.06.

In other Omega Protein news, insider Mark Edward Griffin sold 20,439 shares of Omega Protein stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $21.60, for a total value of $441,482.40. Following the completion of the sale, the insider now owns 85,595 shares in the company, valued at approximately $1,848,852. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Andrew Johannesen sold 5,298 shares of the business’s stock in a transaction dated Friday, December 4th. The stock was sold at an average price of $23.26, for a total value of $123,231.48. Following the sale, the chief financial officer now owns 72,232 shares of the company’s stock, valued at approximately $1,680,116.32. The disclosure for this sale can be found here.

A number of research firms have weighed in on OME. Vetr raised shares of Omega Protein from a “sell” rating to a “hold” rating and set a $21.25 price objective on the stock in a report on Wednesday, November 11th. Zacks Investment Research cut shares of Omega Protein from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 13th. DA Davidson raised their price objective on shares of Omega Protein from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, November 6th. BB&T Corp. restated a “hold” rating on shares of Omega Protein in a research report on Tuesday, October 20th. Finally, Pivotal Research lowered shares of Omega Protein from a “buy” rating to a “hold” rating and set a $19.00 target price on the stock. in a research report on Tuesday, October 20th.

Omega Protein (NYSE:OME) traded down 7.21% during mid-day trading on Monday, hitting $20.60. 418,164 shares of the stock traded hands. Omega Protein has a 12-month low of $10.25 and a 12-month high of $25.22. The stock has a market cap of $458.27 million and a PE ratio of 18.69. The company has a 50 day moving average of $22.88 and a 200-day moving average of $17.83.

Omega Protein (NYSE:OME) last released its quarterly earnings data on Wednesday, November 4th. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.31. The company had revenue of $112.20 million for the quarter, compared to analyst estimates of $100.59 million. The firm’s revenue for the quarter was up 58.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.22 EPS. Equities research analysts forecast that Omega Protein will post $1.67 earnings per share for the current year.

12 Month Chart for NYSE:OME

Omega Protein Corporation is a nutritional product company. The Company operates through two segments: animal nutrition and human nutrition. The animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (NYSE:OME) and Omega Shipyard, Inc. (Omega Shipyard). Omega Protein, the principal operating subsidiary, produces animal nutrition products and operates in the menhaden harvesting and processing business. Omega Shipyard owns and operates a 49.4 acre shipyard facility in Moss Point, Mississippi. The human nutrition segment has three primary product lines: dairy protein products, specialty oils and fatty acids, and other nutraceutical ingredients. The human nutrition business consists of Nutegrity, a division of the Company, consisting of three subsidiaries: Cyvex Nutrition, Inc. (Cyvex), InCon Processing, L.L.C. (InCon) and Wisconsin Specialty Protein, L.L.C. (WSP), and Bioriginal Food & Science Corp. (Bioriginal).

 

Latest News

Oracle Buying Textura at a Price of $663 Million
Oracle Buying Textura at a Price of $663 Million
AB InBev Offering More Assets of SABMiller in Europe to Win EU Approval
AB InBev Offering More Assets of SABMiller in Europe to Win EU Approval
Verizon Working With Authorities On Sabotage Incidents
Verizon Working With Authorities On Sabotage Incidents
UPS Profit Increases During First Quarter by 10%
UPS Profit Increases During First Quarter by 10%
Consumers Buying Fewer Apple Products, Sales Slump Worldwide
Consumers Buying Fewer Apple Products, Sales Slump Worldwide
Boeing Profit Drops on Lag in Commercial Deliveries
Boeing Profit Drops on Lag in Commercial Deliveries


Leave a Reply

 
© 2006-2017 The Vista Voice. Subscribe